CEACAM1 increased the lymphangiogenesis through miR-423-5p and NF- kB in Non-Small Cell Lung Cancer
We found that CEACAM1 enhanced lymphangiogenesis in NSCLC via NF-kB activation and was repressed by miR-423-5p. This suggests the value of CEACAM1 as a new therapeutic marker in NSCLC.
Authors
- Wen-Ke Cai
- Shunqiong Chen (ORCID: https://orcid.org/0000-0002-7911-8284)
- Jie Yu (ORCID: https://orcid.org/0000-0002-1168-8766)
- Wei Guo (ORCID: https://orcid.org/0000-0002-2646-6517)
- Jicui Wang
- Feipeng Zhao (ORCID: https://orcid.org/0000-0002-1522-6606)
- Tao Zhou (ORCID: https://orcid.org/0009-0009-1645-1512)
- Yan Wang (ORCID: https://orcid.org/0000-0001-9536-6571)
- Bo Men
- Dong Tu
Institutions
- Dalian Medical University (CN)
- Kunming Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- People's Liberation Army 401 Hospital (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Biochemistry and Biophysics Reports
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1016/j.bbrep.2024.101833
- Citations
- 3
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.70